Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
International Journal of Hematology, 05/08/2012
Clinical Article
Stasi R et al. – Romiplostim treatment provided greater reductions in all bleeding–related episodes (BREs), as well as BREs involving Ig rescue medications, than did standard of care (SOC).



